Further, to identify key genes related to the prognosis of PAAD patients, we analyzed the overall survival between differentially expressed immune checkpoint (OX40, KIR3DL1, and TNFRSF14) groups. The gene discussed is TNFRSF4; the disease is pancreatic adenocarcinoma.